Bradley & Co Private Wealth Management’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,000	Closed	-$4.24K	–	221
2025 Q3	$4.24K	Hold	1,000	–	–	﹤0.01%	157
2025 Q2	$2.11K	Hold	1,000	–	–	﹤0.01%	172
2025 Q1	$1.22K	Hold	1,000	–	–	﹤0.01%	170
2024 Q4	$1.29K	Buy	+1,000	New	+$2.4K	﹤0.01%	170
2024 Q2	$2.26K	Hold	1,000	–	–	﹤0.01%	156
2024 Q1	$2.39K	Hold	1,000	–	–	﹤0.01%	160
2023 Q4	$1.66K	Hold	1,000	–	–	﹤0.01%	175
2023 Q3	$1.92K	Hold	1,000	–	–	﹤0.01%	157
2023 Q2	$1.44K	Hold	1,000	–	–	﹤0.01%	160
2023 Q1	$2.1K	Hold	1,000	–	–	﹤0.01%	155
2022 Q4	$1.13K	Hold	1,000	–	–	﹤0.01%	162
2022 Q3	$2K	Hold	1,000	–	–	﹤0.01%	166
2022 Q2	$1K	Hold	1,000	–	–	﹤0.01%	177
2022 Q1	$2K	Hold	1,000	–	–	﹤0.01%	143
2021 Q4	$2K	Hold	1,000	–	–	﹤0.01%	148
2021 Q3	$4K	Hold	1,000	–	–	﹤0.01%	147
2021 Q2	$3K	Hold	1,000	–	–	﹤0.01%	152
2021 Q1	$2K	Buy	+1,000	New	+$2.24K	﹤0.01%	158